AI assistant
Sending…
Bone Biologics Corp — Director's Dealing 2022
Feb 28, 2022
35440_dirs_2022-02-28_a358ca47-cafc-4136-8fc1-53e2b0fcd848.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2022-01-03
Reporting Person: Walsh Deina H (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-03 | Employee Stock Option | $3.72 | A | 25000 | Acquired | 2025-01-03 | Common Stock (25000) | Direct |
More from Bone Biologics Corp
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Mar 2
Director's Dealing
2026
Jan 21
Director's Dealing
2026
Jan 21
Regulatory Filings
2026
Jan 8
Interim / Quarterly Report
2025
Nov 14
Major Shareholding Notification
2025
Nov 7
Regulatory Filings
2025
Sep 26
Regulatory Filings
2025
Sep 4
Regulatory Filings
2025
Aug 29